These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23055630)

  • 1. Isoniazid and thioacetazone may exhibit antitubercular activity by binding directly with the active site of mycolic acid cyclopropane synthase: Hypothesis based on computational analysis.
    Banerjee D; Bhattacharyya R
    Bioinformation; 2012; 8(16):787-9. PubMed ID: 23055630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.
    Alahari A; Trivelli X; Guérardel Y; Dover LG; Besra GS; Sacchettini JC; Reynolds RC; Coxon GD; Kremer L
    PLoS One; 2007 Dec; 2(12):e1343. PubMed ID: 18094751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the alpha-mycolic acid.
    Glickman MS
    J Biol Chem; 2003 Mar; 278(10):7844-9. PubMed ID: 12502719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis.
    Huang CC; Smith CV; Glickman MS; Jacobs WR; Sacchettini JC
    J Biol Chem; 2002 Mar; 277(13):11559-69. PubMed ID: 11756461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free enzyme dynamics of CmaA3 and CmaA2 cyclopropane mycolic acid synthases from Mycobacterium tuberculosis: Insights into residues with potential significance in cyclopropanation.
    Annaraj P D; Kadirvel P; Subramanian A; Anishetty S
    J Mol Graph Model; 2019 Sep; 91():61-71. PubMed ID: 31181453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues.
    Coxon GD; Craig D; Corrales RM; Vialla E; Gannoun-Zaki L; Kremer L
    PLoS One; 2013; 8(1):e53162. PubMed ID: 23301038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates.
    Barkan D; Rao V; Sukenick GD; Glickman MS
    J Bacteriol; 2010 Jul; 192(14):3661-8. PubMed ID: 20472794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.
    Rao V; Gao F; Chen B; Jacobs WR; Glickman MS
    J Clin Invest; 2006 Jun; 116(6):1660-7. PubMed ID: 16741578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing quinoline-isoniazid hybrids as potent anti-tubercular agents inhibiting mycolic acid biosynthesis.
    Alcaraz M; Sharma B; Roquet-Banères F; Conde C; Cochard T; Biet F; Kumar V; Kremer L
    Eur J Med Chem; 2022 Sep; 239():114531. PubMed ID: 35759907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing novel inhibitors against cyclopropane mycolic acid synthase 3 (PcaA): targeting dormant state of
    Verma J; Subbarao N
    J Biomol Struct Dyn; 2021 Oct; 39(17):6339-6354. PubMed ID: 32715934
    [No Abstract]   [Full Text] [Related]  

  • 11. The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase.
    Glickman MS; Cahill SM; Jacobs WR
    J Biol Chem; 2001 Jan; 276(3):2228-33. PubMed ID: 11092877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis.
    Belardinelli JM; Morbidoni HR
    Expert Rev Anti Infect Ther; 2013 Apr; 11(4):429-40. PubMed ID: 23566152
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Taira J; Ito T; Nakatani H; Umei T; Baba H; Kawashima S; Maruoka T; Komatsu H; Sakamoto H; Aoki S
    Int J Mycobacteriol; 2017; 6(2):142-148. PubMed ID: 28559515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics investigation of the active site dynamics of mycobacterial cyclopropane synthase during various stages of the cyclopropanation process.
    Choudhury C; Deva Priyakumar U; Sastry GN
    J Struct Biol; 2014 Jul; 187(1):38-48. PubMed ID: 24780591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs.
    Raman K; Rajagopalan P; Chandra N
    PLoS Comput Biol; 2005 Oct; 1(5):e46. PubMed ID: 16261191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREATMENT OF PULMONARY TUBERCULOSIS WITH A COMBINATION OF THIACETAZONE AND ISONIAZID. A PRELIMINARY REPORT.
    MAJUMDAR SS; KARKARE GS; MENON CR
    Indian J Chest Dis; 1965 Jan; 7():26-9. PubMed ID: 14332626
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controlled study of the combination isoniazid-thioacetazone in the treatment of lung tuberculosis].
    do Prado WT; Gomes Sde C
    AMB Rev Assoc Med Bras; 1974 Nov; 20(11):399-402. PubMed ID: 4141511
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoniazid plus thioacetazone compared with two regimens of isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis in South Indian patients.
    Tuberculosis Chemotherapy Centre
    Bull World Health Organ; 1966; 34(4):483-515. PubMed ID: 4161578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THIACETAZONE PLUS ISONIAZID IN DOMICILIARY TREATMENT OF PULMONARY TUBERCULOSIS IN HYDERABAD.
    MENON NK
    Tubercle; 1965 Mar; 46():19-28. PubMed ID: 14296505
    [No Abstract]   [Full Text] [Related]  

  • 20. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
    MITCHISON DA
    Br Med J; 1965 May; 1(5446):1333-40. PubMed ID: 14278838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.